How to Respond to FDA Form 483s and Warning Letters
July 10, 2017
Many medical device manufacturers receive FDA warning letters due to lack of preparation for the FDA inspection and/or an inadequate response to an FDA Form 483.
The manner in which manufacturers respond to the 483 is critical in mitigating potential compliance risks and preventing the issuance of a warning letter. This article by NSF’s Kristen Grumet, published in Medical Design and Outsourcing, explains six key steps manufacturers can take when issued the FDA Form 483.
How NSF Can Help You
Get in touch to find out how we can help you and your business thrive.
What’s New with NSF
NSF Granted Reauthorization as a CMMC Third-Party Assessment Organization
January 8, 2025Cyber AB’s reauthorization allows NSF to conduct CMMC Level 2 assessments and certifications for Department of Defense Suppliers.
Read the Story
Sustainable Foods Summit 2025
January 2, 2025NSF is pleased to support The Sustainable Foods Summit in San Francisco, taking place 22-23 January 2025. The North American edition will delve into sustainability schemes, regenerative agriculture, ecological and packaging impacts.
Read the Story
NSF Celebrates 50 Years of the Safe Drinking Water Act
December 16, 2024The Safe Drinking Water Act resulted in the creation of NSF/ANSI/CAN 60 and NSF/ANSI/CAN 61, helping safeguard global drinking water.
Read the Story
Brooklands New Media’s Publication On NSF’s Global Animal Wellness Standards (GAWS) Not Endorsed by NSF
November 25, 2024NSF is aware that a firm called Brooklands New Media plans to publish a book to mark the 5th anniversary of NSF Global Animal Wellness Standards (GAWS).
Read the Story